Clinical guide · Medical review

Medical review as an enabling discipline

Where senior medical input creates options, protects the central idea and reduces expensive change later.

Pathway Medical · Consumer health medical affairs · 2026

Abstract

This guide reframes medical review as an enabling discipline within consumer health development and communications. It describes where senior medical input creates options, protects the central idea and reduces expensive change later in the process.

Plain-English summary

Medical review is most valuable before wording, design and channel decisions become fixed. Early involvement lets the reviewer identify the strongest credible route instead of simply marking up a near-final execution.

A proportionate review model separates material scientific risk from preference, records the reasoning and gives creative, regulatory and brand teams feedback they can act on.

Key findings

Review the idea early

Test the core promise before a campaign or pack route is fully developed.

Use one evidence position

Keep claims, references and approved scientific language in a controlled source.

Prioritise material risk

Separate essential changes from optional improvements and stylistic preference.

Close the loop

Record final wording, evidence and decisions so future adaptations stay consistent.

How this supports consumer health brands

Earlier review gives teams more room to preserve a compelling idea, improves consistency across channels and creates a cleaner evidence trail for internal approval or external clearance.